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Background: Inconsistent findings of weight change following total knee (TKA) and hip (THA) arthroplasty may
largely be attributable to heterogeneous cohorts and varied definitions of weight loss. This study examined weight
change following TKA and THA for osteoarthritis (OA).
Methods: 64 participants with hip or knee OA were recruited from orthopaedic joint arthroplasty waiting lists at a
single major Australian public hospital between March and October 2011. The Short Form (SF) 12 survey was used
to assess baseline physical and mental functioning. 49 participants completed 6 month follow-up (20 from the THA
group and 29 from the TKA group).
Results: The majority of subjects lost weight (>0 kg) 6 months following THA (70 %) and TKA (58.6 %). When at
least a 5 % reduction in total body weight was used to define clinically significant weight loss, the proportion of
people with weight loss was 37.9 % for TKA and 25 % for THA. Greater weight loss occurred 6 months following
TKA compared with THA (7.2 % versus 3.7 % of body weight; p = 0.04). Worse pre-operative physical functioning
(SF-12) was associated with greater weight loss following TKA (β = 0.22 kg, 95 % CI 0.02-0.42 kg; p = 0.04).
Conclusion: Most people lost weight (>0 kg) 6 months following TKA and THA and a considerable proportion of
people achieved ≥5 % loss of body weight. The magnitude of weight loss was greater following TKA than THA,
with worse pre-operative function being a predictor of more weight loss. Further attention to weight management
is required to assist a greater number of people to achieve a larger magnitude of weight loss following knee and
hip joint arthroplasty.
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 Inconsistent findings of weight change following
total knee (TKA) and hip (THA) arthroplasty may
largely be attributable to heterogeneous cohorts and
varied definitions of weight loss.
 We confirm that the majority of people achieve
some weight loss following TKA or THA, with the
magnitude being greater following TKA.* Correspondence: Flavia.cicuttini@monash.edu
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creativecommons.org/publicdomain/zero/1.0/) ap Poorer pre-operative physical functioning helps to
predict individuals who will lose more weight
following TKA.Background
Total knee (TKA) and hip (THA) arthroplasty are com-
monly performed for the management of painful end-
stage osteoarthritis (OA). Although patient satisfaction
rates have been shown to be approximately 90 % follow-
ing TKA or THA for OA in the Australian public
healthcare system [1], studies examining post-operative
outcomes have focused on pain, joint function and activ-
ity limitations. However despite only minimal, if any,
post-arthroplasty improvement in physical activity levelsticle distributed under the terms of the Creative Commons Attribution
4.0), which permits unrestricted use, distribution, and reproduction in any
redited. The Creative Commons Public Domain Dedication waiver (http://
plies to the data made available in this article, unless otherwise stated.
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recognised risk factor for both end-stage hip and knee
OA, and it is therefore important to determine whether
arthroplasty augments weight-management. In a global
context, the recent 11th annual report from the United
Kingdom Joint Registry, which examined surgical out-
comes, focused mainly on mortality and revision rates
[5]. The paucity of data concerning weight loss post-
arthroplasty is however surprising, given that as little as
1 % loss of weight results in a reduction in the rate of
cartilage volume loss and an improvement in knee pain,
stiffness and function [6], which may have implications
for the contralateral knee and other joints. A recent sys-
tematic review was unable to make any conclusions
about weight or body composition changes after joint
arthroplasty [7].
There are a number of reasons for the inconsistent re-
sults among the few studies examining post-operative
weight change. A major issue is the heterogeneity of the
examined cohorts. For instance, while some studies in-
cluded people with both inflammatory arthritides and
OA [8–12], other studies pooled results from TKA and
THA [9]. Outcome methods have also varied. Whereas
some studies have employed “any weight loss” as an out-
come [8, 13–15], other studies have used at least 5 %
body weight to signify clinically meaningful weight loss
[9, 11, 12, 16, 17]. However, a commonality among these
studies is that there are a proportion of people who gain
and lose weight, while others remain weight neutral.
This raises the possibility of identifying key characteris-
tics that could stratify the likelihood of post-arthroplasty
weight loss.
The aim of this prospective study was to i) examine
weight change in people following total knee and hip
joint arthroplasty for OA and ii) to determine factors




This study was a prospective case series that recruited
participants between March 1 and October 15, 2011,
from the Alfred, a major tertiary referral public hospital
in Melbourne, Australia.
Inclusion criteria were age between 50 and 80 years
(inclusive), a diagnosis of hip or knee OA, and waitlist-
ing for a primary THA or TKA. Only participants
undergoing their first (primary) joint replacement were
included. Participants who were in high-level care facil-
ities (such as nursing homes) or were requiring a wheel-
chair were excluded. A lower age cut-off of 50 was
chosen in an attempt to reduce the potential for
non-OA indications for surgery (e.g. inflammatory ar-
thritides such as ankylosing spondylitis). Participantswith comorbidities that significantly affected their level
of physical activity such as a previous stroke and those
with English language or cognitive barriers were also ex-
cluded. A total of 141 adults waitlisted for an elective
THA or TKA attended the preadmission clinic between
March and October 2011. Seventy-seven adults met the
eligibility criteria and 64 people were recruited for the
study. Of these, 49 completed 6-month follow-up. Partic-
ipants completing follow-up were no different in relation
to their baseline demographics (age, gender and BMI)
than those who had not completed the study (data not
shown). Written informed consent was obtained.
The type of prosthesis used for surgery was chosen by
the individual orthopaedic consultant but was limited at
the femoral side to either the Corail ® Total Hip System
(DePuy Orthopaedics Inc., Warsaw, IN, USA) (for unce-
mented THA) or the Exeter Hip (Stryker Orthopaedics,
Mahwah, NJ, USA) (for cemented THA). A Pinnacle or
Duraloc ® System (DePuy Orthopaedics Inc), or a
Trident (Stryker Orthopaedics) was available for the ace-
tabular component. The GENESIS II (Smith & Nephew
Inc, Memphis, TN USA) or Stryker ® Triathlon (Stryker
Orthopaedics) prosthesis was used for all TKAs. All
participants were managed with the same postopera-
tive protocol and were permitted to weightbear as
tolerated. During the inpatient post-operative phase,
routine post-operative care included daily physiotherapy
(mobilization day 1 post-operatively) and a bed-based
exercise program. Sixty-one percent of participants
were discharged home with ongoing outpatient physio-
therapy provided by community services. The remaining
participants were discharged to inpatient rehabilitation
centres.
Preoperative data were collected at the preadmission
clinic by an allied health assistant. Followup data were
collected at the routine 6-month postoperative review
appointment by an orthopaedic outpatient physiotherap-
ist. Baseline participant information pertaining to age,
sex, comorbidities, height, weight, and body mass index
(BMI) was extracted from the anaesthetic assessment
conducted at the preadmission clinic and recorded in
the medical history. Comorbidities were categorized
as cardiovascular, diabetes, respiratory, musculoskeletal
(excluding the affected hip or knee), or other. Since par-
ticipants could have more than one comorbidity in each
category, the total number of comorbidities was also
recorded. The Short Form (SF) 12 version 1, which con-
tains twelve questions regarding physical and emotional
well-being to determine a physical component and mental
component summary score (PCS and MCS respectively),
was also collected at baseline [18]. A lower SF-12 score in-
dicated poorer physical or mental health.
At the 6 month postoperative review, weight was mea-
sured to the nearest 0.1 kg (shoes, socks, and bulky
Table 1 Subject characteristics
THA TKA P
(n = 20) (n = 29)
Baseline
Age (years) 69.5 (8.8) 67.4 (8.3) 0.41
Gender (% female) 65 % 65.5 % 0.97*
Weight (kg) 79.4 (19.2) 83.8 (19.2) 0.43
Height (m) 1.64 (0.11) 1.63 (0.11) 0.76
BMI (kg m−2) 29.2 (4.9) 31.5 (6.3) 0.16
Length of stay (days) 6.0 (1.8) 7.1 (5.6) 0.31
PCS 28.9 (5.8) 31.7 (8.4) 0.18
MCS 39.2 (13.6) 45.1 (12.8) 0.13
Co-morbidities (%)
Cardiovascular disease 65 55 0.58*
Diabetes mellitus 20 21 0.98*
Respiratory 15 10 0.61*
Musculoskeletal 35 34 0.87*
Average number of comorbidities 2.9 (2.1) 2.4 (1.5) 0.35
Follow-up
BMI (kg m−2) 28.6 (5.0) 30.5 (6.4) 0.25
Weight (kg) 77.5 (19.2) 81.0 (18.9) 0.54
Change
BMI (kg m−2) −0.68 (1.08) −1.07 (1.80) 0.35
Weight (kg) −1.84 (2.95) −2.86 (4.82) 0.36
Weight (%) −2.4 (4.0) −3.3 (5.7) 0.51
Weight loss
Number of people who lost weight
n (%)
14 (70) 17 (58.6) 0.42*
BMI reduction (kg m−2) −1.1 (0.2) −2.2 (0.4) 0.02
Weight (kg) −3.09 (2.57) −5.93 (3.92) 0.02
Weight (%) −4.1 (3.4) −6.9 (4.7) 0.06
>5 % body weight reduction, n, (%) 5 (25) 11 (37.9) 0.34*
Weight gain
Number of people who gained weight
n (%)
4 (20) 10 (34.5) 0.27*
BMI increase (kg m−2) 0.6 (0.3) 0.7 (0.3) 0.48
Weight (kg) 1.7 (0.8) 1.8 (1.1) 0.66
Weight (%) 2.4 (1.5) 2.3 (1.6) 0.37
>5 % body weight gain, n, (%) 0 (0) 1 (10) 0.51*
Unless otherwise stated, results displayed as mean (standard deviation)
P-values derived from independent t-tests (excluding * which indicates
Chi-square analyses)
PCS/MCS – physical/metal components score from Short-Form 12 survey
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Height was measured to the nearest 0.1 cm (shoes and
socks removed) using a stadiometer. From these data,
body mass index [BMI (kg m−2)] was calculated. At fol-
lowup information from the medical file regarding length
of stay in hospital and adverse events was recorded.
This study was approved by the Alfred Hospital Research
Ethics Committee.
Statistical analyses
Independent t-tests were used to compare unadjusted
differences in the characteristics between subjects under-
going TKA and THA. General linear models were used
and estimated marginal means (EMMs) were created,
adjusting for age, gender and the number of comorbidi-
ties to determine whether the magnitude of weight loss
differed between people following TKA or THA. The
primary outcome measures were change in BMI,
weight (kg) and percentage weight. Based on previous
data [13] we estimated a sample size of approxi-
mately 26 participants in each group would enable
80 % power to detect statistically significant differ-
ences in weight (kg) change among people undergoing
TKA and THA (p = 0.05, two-tailed). Linear regression
analyses were used to examine the relationships between
baseline variables and weight change following joint
arthroplasty. A p-value of less than 0.05 (two-tailed) was
considered statistically significant. All analyses were per-
formed using SPSS statistical package (standard version
21.1 SPSS, Chicago, IL, USA).
Results
Twenty subjects who underwent THA and 29 subjects
who underwent TKA completed follow-up (Table 1).
There were no significant differences in the baseline
characteristics between people who completed follow-up
(n = 49) and those who did not (n = 64) (data not
shown). Reasons for loss to follow-up included declining
surgery (n = 8) and non-attendance at follow-up (n = 7).
At baseline, 9 (45 %) people having THA were over-
weight (BMI ≥ 25–30 kgm−2), while 8 (40 %) were obese or
heavier (BMI ≥ 30 kgm−2). Ten (34 %) people proceeding
to TKA were overweight (BMI ≥ 25–30 kgm−2) while 16
(55 %) were obese or heavier (BMI ≥ 30 kgm−2). The
pooled cohort had a mean BMI of 30.6 ± 5.9 kgm−2.
Seventy percent of subjects who had a THA, and
58.6 % of subjects who had a TKA lost weight (>0 kg),
although this was reduced to 25 % and 37.9 % respect-
ively when a 5 % threshold of weight loss was required.
Using the 5 % weight change criterion, only one subject
(<2 % of the cohort) gained weight, although 34.5 % of
TKA patients gained weight (>0 kg), while 20 % of THA
patients gained weight (>0 kg). Significantly more weight
loss occurred 6 months following TKA compared withTHA (5.9 kg versus 3.1 kg; p = 0.02). Post-operative
complications for participants completing 6 month
follow-up are shown in Table 2.
Estimated marginal means for the amount of weight
loss are presented in Table 3 After adjusting for baseline
Table 2 Post-operative complications for people completing
follow-up (Within 6 months of arthroplasty)
THA TKA
(n = 20) (n = 29)
Mortality 0 (0.0) 0 (0.0)
Deep vein thrombosis 1 (5.0) 0 (0.0)
Post-operative hypotension 1 (5.0) 1 (3.4)
Wound ooze 4 (20.0) 2 (6.8)
Septic arthritis 0 (0.0) 1 (3.4)
Haematoma 1 (5.0) 1 (3.4)
Acute renal failure 0 (0.0) 1 (3.4)
Inpatient fall 0 (0.0) 1 (3.4)
Manipulation under anaesthetic 0 (0.0) 4 (13.8)
Results represented by frequency (%)
Table 4 Baseline variables and post-arthroplasty weight
change (Kg)
THA TKA
Multivariate* P Multivariate* P
β (95 % CI) β (95 % CI)
Age −0.06 (−0.29, 0.18) 0.62 −0.08 (−0.32, 0.16) 0.50
Gender −0.49 (−5.1, 4.1) 0.82 −3.45 (−7.54, 0.65) 0.10
Weight −0.02 (−0.13, 0.09) 0.70 −0.10 (−0.20, 0.01) 0.07
Number of
comorbidities
0.03 (−0.92, 0.97) 0.95 −0.76 (−2.04, 0.53) 0.24
PCS 0.14 (−0.29, 0.57) 0.51 0.22 (0.02, 0.42) 0.04
MCS −0.02 (−0.17, 0.14) 0.81 −0.08 (−0.25, 0.09) 0.35
*Adjusted for baseline age, gender, weight and number of comorbidities
PCS/MCS – physical/mental components score from Short-Form 12 survey
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was a significantly greater reduction in measures of
obesity following TKA compared with THA: BMI
(2.3 kg m−2 versus 1.2 kg m−2; p = 0.03), weight (5.8 kg
versus 3.2 kg; p = 0.05) and percentage body weight
(7.2 % versus 3.7 %; p = 0.04).
The relationships between baseline characteristics and
post-operative weight loss are shown in Table 4. After
adjusting for potential confounders, pre-operative phys-
ical functioning (SF-12) was associated with weight
change following TKA (β = 0.22 kg, 95 % CI 0.02-
0.42 kg; p = 0.04). That is, for every 1 point worsening
score in baseline physical functioning, there was 0.22 kg
weight loss following TKA. No examined variables were
associated with weight loss following THA.
Discussion
This study has demonstrated that the majority of
subjects lose weight following TKA and THA, al-
though the magnitude of weight loss is significantly
greater following TKA. Worse pre-operative physical
functioning was associated with greater weight loss
following TKA.
A recent systematic review was unable to conclude
whether or not weight loss is a common post-
arthroplasty occurrence [7]. A major reason for theTable 3 Estimated marginal means for weight loss
Crude (SEM) Adjusted (SEM)a
THA TKA P THA TKA P
(n = 14) (n = 17) (n = 14) (n = 17)
BMI (kg m−2) 1.1 (0.5) 2.2 (0.5) 0.02 1.1 (0.3) 2.3 (0.3) 0.03
Weight (kg) 3.1 (0.9) 5.9 (0.8) 0.02 3.2 (0.9) 5.8 (0.8) 0.05
Weight (%) 4.1 (1.1) 6.9 (1.0) 0.06 3.7 (1.1) 7.2 (1.0) 0.04
aEstimated marginal means adjusted for baseline age, gender, weight and number
of comorbiditiesinconsistent results among past studies is related to the
heterogeneity of the populations studied and the out-
come measures employed. For instance, while some
studies included people with both inflammatory arthriti-
des and OA [8–12], other studies pooled results from
TKA and THA [9]. The current study has selected
people undergoing TKA and THA for OA and analysed
these groups separately. We confirm that the majority of
people lost weight (>0 kg) 6 months post-operatively
(58.6 % for TKA and 70 % for THA). Although a more
stringent cut-off for weight loss (≥5 % body weight) re-
duced the number of people achieving this target, a con-
siderable proportion of people (37.9 % following TKA
and 25 % following THA) were still able to achieve this
threshold. Taken together, these results suggest that
while the majority of people achieve some weight loss
following either TKA or THA, further attention to
weight management in the post-operative period may as-
sist a greater number of people achieve a larger magni-
tude of weight loss following knee and hip joint
arthroplasty. Using the 5 % weight change criterion, only
one subject (<2 % of the cohort) gained weight, although
34.5 % of TKA patients gained weight (>0 kg), while
20 % of THA patients gained weight (>0 kg).
In this study, we have demonstrated that the magni-
tude of weight loss is significantly greater following TKA
compared with THA. This is an important distinction,
given that there is evidence that metabolic syndrome is
more common with knee rather than hip OA [19], while
obesity is also associated with the need for bilateral TKA
in OA [20, 21]. In this study, the BMI of people with
end-stage knee OA requiring joint arthroplasty was
greater than that for hip OA, although the difference
was not statistically significant. Weight loss imparted by
TKA may therefore be a potential means of reducing the
burden of the metabolic syndrome, and may even help
to manage possible co-existing disease in the contralat-
eral knee. We have shown that even as little as 1 % loss
Teichtahl et al. BMC Musculoskeletal Disorders  (2015) 16:137 Page 5 of 6of weight results in a reduction in the rate of cartilage
volume loss and an improvement in knee pain, stiffness
and function [6], so that the effect of weight-loss
imparted by surgery may be beneficial to the non-
operated native knee. These hypotheses do however re-
quire substantiation in future studies. Moreover, this is
the first study to examine and identify a determinant of
weight loss following arthroplasty. Previously it had been
demonstrated that patients with worse pre-operative
function had the greatest outcomes following TKA, as
determined by a composite physical function score [22].
Similarly, the current study found that people with
worse physical function preceding TKA had the greatest
weight loss post-operatively. This may have occurred
because the intervention (TKA) improved activity
levels, subsequently promoting greater energy expend-
iture and weight loss. Nevertheless, such claims re-
quire substantiation and it has been shown that TKA
at best, only modestly improves physical activity levels
[2]. Despite our cohort self-reporting greater physical
activity post THA or TKA, no objective increase in
physical activity was demonstrable post-operatively [3].
Regardless of the mechanism, these data support the
possibility of identifying a subgroup of people who
may, as an adjunct to having their end-stage OA
treated by arthroplasty, also derive weight manage-
ment benefits.
Despite this prospective study being limited by its
modest sample size, we had adequate power to demon-
strate between group differences in weight-loss. This
was a single-center study conducted in a public hospital
over a 6 month follow-up duration. Although this was a
strength of the study since no potential confounding
from different acute and sub-acute protocols across mul-
tiple care-settings was introduced, multi-center studies
examining outcomes in both public and private hospitals
over longer durations are required to substantiate the
generalizability of this study’s findings. Moreover, we
have used crude measures for assessing changes in
weight. Given forced immobility can occur in the imme-
diate post-operative setting, body composition studies
would help to determine whether fat or fat free mass
accounts for the loss in body mass following joint
arthroplasty. Nevertheless, our follow-up of 6 months is
likely to have been sufficient time for rehabilitation and
conditioning to have reversed any acute loss of fat free
mass secondary to deconditioning. We advocate the
need for body composition studies to further examine
this concept. Moreover, we acknowledge that physical,
mental and social factors all influence weight change in
both the pre and post-operative period. A better under-
standing of how these biopsychosocial factors influence
weight management in orthopaedic settings may assist
patients to achieve weight loss.Conclusions
Most people lost weight (>0 kg) 6 months following
TKA and THA and a considerable proportion of people
achieved ≥5 % loss of body weight. The magnitude of
weight loss was greater following TKA than THA, with
worse pre-operative function being a predictor of more
weight loss. Further attention to weight management is
required to assist a greater number of people to achieve
a larger magnitude of weight loss following knee and hip
joint arthroplasty.
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